Clinical trial NCT05836142: Stabilometry and Plantar Pressures Changes After Progressive Pressure Release in Flexor Digitoum Brevis in Latent Trigger Points
Official title: Stabilometry and Plantar Pressures Changes After Progressive Pressure Release in Flexor Digitoum Brevis in Latent Trigger Points
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Bilateral Latent Myofascial Trigger Points of Flexor Digitorum Brevis
Keywords: Foot
Stabilometry
Platform
therapeutics
trigger point
Lead sponsor: Mayuben Private Clinic
Sponsor class: OTHER
First posted: 2023-05-01
Enrollment: 18
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Pretest posttest of bilateral Flexor digitorum Brevis progressive pressure release intervention
Primary purpose: TREATMENT

Brief summary: The aim of this clinical trial is to check the effects of progressive pressure release in the Flexor digitorum Brevis

Detailed description: Eighteen subjects with bilatereal lantent myofascial trigger points wil be recruited for a pre- test post-test study. Participants will be from 18 to 40 years old, not obese. Participants will be measured before and after bilateral dry needling in Flexor digitorum Brevis. The investigators will measure stabilometry variables and static footprint. The footprint variables will be divided in bilateral rear foot, bilateral midfoot, bilateral fore foot.

Stabilometry will be measured by displacement of the center of pressures in X and Y with eyes open and closed , center of pressure (COP) with eyes open and closed, COP area with eyes open and closed, COP antero-posterior (a-p) and medio-lateral (m-lat) directions with eyes open and closed, and COP speed. Two trials will be recorded for each condition and the order of the conditions will be randomized across subjects, eyes open and eyes closed. Foot plantar pressure and surface area of two static footprints will be measured during bipedal standing. Static plantar pressure will be evaluated by means of maximum pressure, medium pressure and surface area of each aspect of the foot (rearfoot, midfoot, and fore foot).

Eligibility criteria: Inclusion Criteria:

* Asyntomatic subjects with flat foot

Exclusion Criteria:

* Previous lower extremities surgery. History of lower extremities injury with residual symptoms (pain, "giving-away" sensations) within the last year.

Leg-length discrepancy more than 1 cm Balance deficits (determined by oral questionnaire regarding falls)

Primary outcomes:
measure: Static footprint
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable x displacement open eyes before progressive pressure release
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable y displacement open eyes before progressive pressure release
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure area open eyes before progressive pressure release
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction open eyes before progressive pressure release
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction open eyes before progressive pressure release
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable x displacement before progressive pressure release with closed eyes
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable y displacement before progressive pressure release with closed eyes
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure area before progressive pressure release with closed eyes
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction before progressive pressure release with closed eyes
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction before progressive pressure release with closed eyes
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable x displacement open eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable y displacement open eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure area open eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with open eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with open eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable x displacement with closed eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable y displacement with closed eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure area with closed eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with closed eyes after intervention
timeFrame: Through study completion, an average of 3 days
measure: Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with closed eyes after intervention
timeFrame: Through study completion, an average of 3 days
Secondary outcomes:
Other outcomes:
Locations:
city: Madrid
country: Spain
facility: Eva María Martínez-Jiménez In Mayuben CLinic
Study officials:
References: